ClinicalTrials.Veeva

Menu

Prophylactic Antibiotic in Subtalar Fusion Surgery

A

Assiut University

Status and phase

Not yet enrolling
Phase 3
Phase 2

Conditions

Surgical Site Infection

Treatments

Drug: Ceftriaxone 2000 mg

Study type

Interventional

Funder types

Other

Identifiers

NCT06527989
antibiotic prophylaxis

Details and patient eligibility

About

Assessment of surgical site infection when using postoperative antibiotic prophylaxis in subtalar fusion surgery 24hours versus 5 days

Full description

Infection in orthopedic surgery is one of the most dreaded complications. Antibiotic prophylaxis should be utilized routinely in foot and ankle surgeries involving bone, utilizing hardware and prosthetic joints.

It is appropriate for the antibiotics to be administered within 60 minutes prior to surgery, discontinued within 24 hours after surgery, given prior to tourniquet inflation, and utilized routinely in prolonged foot and ankle surgery cases.

Narrow spectrum antibiotics covering Staphylococcus aureus should be utilized for prophylaxis in patients without a history of resistant infection. According to American Society of Health System Pharmacists (ASHP) cefazolin was the most used antibiotic in preoperative prophylaxis, combination of cefazolin with gentamicin was the second common regimen while 3rd generation cephalosporin were 3rd widely used antibiotics.

The controversy persists in administration of antibiotics varying from a single dose to 3 doses to 5 days or 14 days. In subtropical country, with a hot and humid climate is a conducive environment for both Gram-positive and Gram-negative bacterial colonization of skin. Therefore, we need studies tailored to our environment in Egypt Prevention of SSIs is critical for the health of patients, Economic efficiency, Antibiotic resistance considerations In conclusion, in many ways, the topic of prophylactic antibiotics in elective foot and ankle surgery is an unusual one, in that a relative divide exists between empirical science and common practice.

Enrollment

102 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. posttraumatic subtallar osteoarthritis
  2. adult age 18 up to 60
  3. good skin condition healthy

Exclusion criteria

  1. comorbidities such as Diabetes Mellitus, Autoimmune diseases
  2. previous foot surgery
  3. wounds near surgical incision
  4. skin infection

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

102 participants in 2 patient groups

ceftriaxone 2 grams
Experimental group
Description:
Single dose 2grams of ceftriaxone in 1st 24 hr Postoperative
Treatment:
Drug: Ceftriaxone 2000 mg
ceftriaxone 10 grams
Experimental group
Description:
Multiple doses 2 grams of ceftriaxone every 24 hrs for 5 days
Treatment:
Drug: Ceftriaxone 2000 mg

Trial contacts and locations

0

Loading...

Central trial contact

Ibram R Labib; Amr A Elsayed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems